Are you looking for an exciting job opportunity? Look no further! McKinney RSA is now hiring a talented individual to […] Read More
3 min. read
Resources
3 min. read
TSRC (S)-6-Methylnicotine Presentation Summary
We have summarized our recent presentation, Identifying Potential Acute Health Hazards from Exposures to (S)-6-Methylnicotine to Inform Product Development, from the Tobacco Science Research Conference. This overview covers key findings and insights contributing to ongoing research in the field. Read More
1 min. read
McKinney RSA is now certified as a small, minority-owned business.
We are proud to announce that McKinney RSA is now officially certified as a small, minority-owned business (SMBE) through the […] Read More
2 min. read
Cannabis Science Conference 2024 Recap
We recently had the pleasure of participating in the Cannabis Science Conference 2024, a premier event that brought together industry leaders, scientists, and regulatory experts to share their insights and advancements in the field. Our social media coverage highlighted several key moments from the conference, showcasing the breadth of knowledge and innovation present. Read More
2 min. read
CannMed24 Conference Recap: Pioneering the Future of Cannabis in Biopharma
The CannMed24 conference, held from May 12-15, was a valuable event for professionals in the cannabis and biopharma industries. This year’s gathering highlighted the burgeoning partnership between biopharma companies and the cannabis sector, driven by both anecdotal evidence of cannabis' benefits and an increasing demand for scientifically rigorous research and development. Read More
3 min. read
Exclusive Insights – Quitting Camel Country
Here’s what Cheryl Olson says she learned while writing her latest Tobacco Reporter article, about smoking and harm reduction in Middle East nations. Read More
2 min. read
Q&A Segment from Keller and Heckman Symposium
In this Q&A session, experts explore the implications of label inaccuracies in CBD products and the potential behavioral effects of high concentrations. They highlight trends in psychosis associated with Delta-8 THC, possibly due to contamination or misuse for mental health issues. The discussion underscores the need for better regulation and manufacturing practices to ensure product safety and consumer protection. Read More
5 min. read
Keller and Heckman Symposium Panel January 2024
In this discussion, industry experts delve into the complexities of PMTA approvals and the impact of FDA regulations on the tobacco and nicotine sectors. They highlight the importance of innovation, the need for comprehensive scientific data, and the challenges posed by shifting regulatory landscapes. Discover how professionals are advocating for more consistent tools and guidance to ensure industry survival and public health. Read More
3 min. read
Preparing for Tomorrow: Leveraging Tobacco Regulation Insights for Cannabis’s Regulatory Future
Understanding the regulatory landscapes of both the nicotine and cannabis industries is paramount for any business operating within these sectors. In this speech, we will explore the parallels between the nicotine and cannabis spaces, drawing on valuable lessons learned from the nicotine industry that can be effectively applied to the burgeoning cannabis market. Read More
Contact Us
"*" indicates required fields